A nanotechnology driven effectual localized lung cancer targeting approaches using tyrosine kinases inhibitors: Recent progress, preclinical assessment, challenges, and future perspectives
This is promising data that supports the need for further studies evaluating whether GLP-1 receptor antagonists can reduce risk in this population at high risk for developing cancer. 1 What are next steps for GLP-1 research in this population
Systemic translocation of Staphylococcus drives autoantibody production in HIV disease
The results have been consistently promising, showing accelerated regeneration and improved functional outcomes with minimal adverse effects
doi: 10.3389/fendo.2025.1570603 Received 03 February 2025 Accepted 29 April 2025 Published 21 May 2025 Volume 16 - 2025 Edited by Jared Rutter, The University of Utah, United States Reviewed by Steven Patterson, Glasgow Caledonian University, United Kingdom Elena Jimenez Marti, University of Valencia, Spain Nigel Irwin, Ulster University, United Kingdom Updates Copyright 2025 Koefoed-Hansen, Helsted, Kizilkaya, Lund, Rosenkilde and Gasbjerg
